Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Juliane Ladhoff"'
Autor:
Yoshiaki Hara, Tilo Dehne, Katja Kotsch, Petra Reinke, Martina Seifert, Meaghan Stolk, Hans-Dieter Volk, Jochen Ringe, Juliane Ladhoff, Anja Reutzel-Selke
Publikováno v:
Transplant International. 24:1112-1123
Brain death and prolonged cold ischemia are major contributors to the poorer long-term outcome of transplants from deceased donor kidney transplants, with an even higher impact if expanded criteria donors ('marginal organs') are used. Targeting ische
Autor:
Martina Schleicher, Alexandra Bayrak, Ulrich A. Stock, Juliane Ladhoff, Martina Seifert, Maria Tyralla, Hans-Dieter Volk
Publikováno v:
Biomaterials. 31:3793-3803
Several tissue engineering approaches for the treatment of cardiovascular diseases are based on a xenogeneic extracellular matrix. However, the application of engineered heart valves has failed in some patients, causing severe signs of inflammation b
Autor:
Jakob Reiser, Annette Busch, Juliane Ladhoff, Sabine Schu, Martina Seifert, Florian Beyer, Hans-Dieter Volk, Sabine Broesel, Roberto F. Nicosia, Cornelia Doebis
Publikováno v:
Cardiovascular Research. 72:331-338
Objective: In vitro endothelialization has significantly improved the overall outcome of artificial prostheses in cardiovascular bypass surgery. A drawback of this tissue-engineering method remains the limited availability of suitable autologous endo
Autor:
Juliane Ladhoff, Thomas von Zglinicki, Carmen Martin-Ruiz, Gabriele Saretzki, Wenyi Wei, Jessie C. Jeyapalan, John M. Sedivy, Joanne Petrie
Publikováno v:
Journal of Biological Chemistry. 279:17826-17833
The replicative life span of human fibroblasts is heterogeneous, with a fraction of cells senescing at every population doubling. To find out whether this heterogeneity is due to premature senescence, i.e. driven by a nontelomeric mechanism, fibrobla
Autor:
Martina, Seifert, Juliane, Ladhoff
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 1029
Evaluation of the immunogenicity of embryonic stem cell derived differentiated cells is important for their potential application in cell replacement therapies and transplantations. Low immunogenicity or even an immune privileged status would enable
Autor:
Juliane Ladhoff, Martina Seifert
Publikováno v:
Methods in Molecular Biology ISBN: 9781627034777
Evaluation of the immunogenicity of embryonic stem cell derived differentiated cells is important for their potential application in cell replacement therapies and transplantations. Low immunogenicity or even an immune privileged status would enable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1a9ca4f5ed1d044480c787082c56ce4
https://doi.org/10.1007/978-1-62703-478-4_4
https://doi.org/10.1007/978-1-62703-478-4_4
Autor:
Franziska Scheibe, Juliane Ladhoff, Martina Seifert, Katja Blazej, Josef Priller, Arif Oersal, Maik Grohmann, Nevena Baeva, Jojanneke H J Huck
Publikováno v:
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 32(8)
Preclinical trials confirmed the potential of mesenchymal stromal cells (MSCs) to improve functional recovery after experimental stroke. Beneficial effects of MSCs are often attributed to their immunosuppressive/immunomodulatory functions. Surprising
Autor:
Yoshiaki, Hara, Meaghan, Stolk, Jochen, Ringe, Tilo, Dehne, Juliane, Ladhoff, Katja, Kotsch, Anja, Reutzel-Selke, Petra, Reinke, Hans-Dieter, Volk, Martina, Seifert
Publikováno v:
Transplant international : official journal of the European Society for Organ Transplantation. 24(11)
Brain death and prolonged cold ischemia are major contributors to the poorer long-term outcome of transplants from deceased donor kidney transplants, with an even higher impact if expanded criteria donors ('marginal organs') are used. Targeting ische
Publikováno v:
Cardiovascular research. 88(1)
Aims The application of autologous endothelial progenitor cells (EPC) is a promising approach in cardiovascular regeneration, but the availability of cells in appropriate numbers is the limiting factor. Allogeneic EPC would be an alternative, and we
Autor:
Mareen Matz, Hans-H. Neumayer, Mir-Farzin Mashreghi, Klemens Budde, Ulrike Weber, Christine Lorkowski, Juliane Ladhoff, Stefan Kramer
Publikováno v:
Publons
Background. The novel immunosuppressive agent AEB071 is currently being evaluated for its capability to prevent rejection after kidney transplantation as a potential adjunct to calcineurin inhibitor-based regimen. AEB071 is a selective protein kinase